Head and Neck Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Free head and neck screening available at Holzer Center for Cancer Care - Jackson County Times-Journal



Free head and neck screening available at Holzer Center for Cancer Care 
Jackson County Times-Journal
Holzer Center for Cancer Care will offer free oral, head and neck cancer screenings on Saturday, Dec. 9 from 9 a.m. to 1 p.m. at their location in Gallipolis, Ohio. This free screening aims to catch cancers that arise in the nasal cavity, sinuses, lips ...
Head and Neck Cancer Treatment Market Report: Comparative Analysis of the Key Vendors and Market Growth ... MilTech

all 5 news articles » 


Performing Oral Sex May Increase the Chance of Cancer in Men - Big Think



Big Think
 
Performing Oral Sex May Increase the Chance of Cancer in Men 
Big Think
The most commonly transmitted STD in the U.S. is human papillomavirus (HPV), and the incidence of HPV-related oropharyngeal cancer ? head and neck cancer ? has more than doubled over the last 20 years. The oncogenic oral HPV virus occurs in 3.5% ...

 


Celldex launches mid-stage study of CDX-3379 in head and neck cancer - Seeking Alpha



Celldex launches mid-stage study of CDX-3379 in head and neck cancer 
Seeking Alpha
Celldex Therapeutics (CLDX +0.4%) initiates an open-label Phase 2 clinical trial assessing CDX-3379, in combination with Eli Lilly's (LLY -0.1%) ERBITUX (cetuximab), in patients with advanced head and neck squamous cell carcinoma (HNSCC) who do not ...

and more » 


Head and Neck Cancers Are on the Rise Among Younger Men ... - Men's Health



Men's Health
 
Head and Neck Cancers Are on the Rise Among Younger Men ... 
Men's Health
For a long time, experts knew that HPV could raise a woman's risk for cervical cancer. But there didn't appear to be much risk for HPV-infected men.
Beware! Oral sex can cause head and neck cancer - NewsBytes NewsBytes

all 3 news articles » 


Durvalumab Has Emerging Role in Head and Neck Cancer - OncLive



OncLive
 
Durvalumab Has Emerging Role in Head and Neck Cancer 
OncLive
In an interview with OncLive, Dan Zandberg, MD, an assistant professor at the University of Maryland School of Medicine, discussed results from the HAWK study as well as current combination approaches for patients with head and neck cancer.

 


Recent Advances in Head and Neck Squamous Cell Cancer - Targeted Oncology



Targeted Oncology
 
Recent Advances in Head and Neck Squamous Cell Cancer 
Targeted Oncology
Head and neck squamous cell cancer is relatively uncommon in the United States compared to other malignancies like non-small?cell lung cancer and breast ...

and more » 


Proton Therapy Beneficial for Children with Head and Neck Cancers - Specialty Pharmacy Times



Proton Therapy Beneficial for Children with Head and Neck Cancers 
Specialty Pharmacy Times
Proton beam therapy (PBT) may be a better treatment option for pediatric patients with head and neck cancers than first-line therapy with traditional photon ...

and more » 


Role of Immunotherapy Expanding in Head and Neck Cancer - OncLive



OncLive
 
Role of Immunotherapy Expanding in Head and Neck Cancer 
OncLive
Immunotherapy and novel multikinase inhibitors continue to play an important role for patients with head and neck cancer, particularly as ongoing clinical trials ...

and more » 


Head and Neck Cancer Market Comprehensive Insights 2017 to 2025 - Research of Market



Head and Neck Cancer Market Comprehensive Insights 2017 to 2025 
Research of Market
Head and Neck cancer (HNC)-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Head and Neck cancer (HNC). The report provides a complete understanding of the ...

and more » 


Why This Biotech Could Prosper On Back Of Roche Cancer Trial - Investor's Business Daily



Investor's Business Daily
 
Why This Biotech Could Prosper On Back Of Roche Cancer Trial 
Investor's Business Daily
As a result, Marai sees a potential role for cabiralizumab in treating tumors that have a high number of TAMs like advanced lung, ovarian and head and neck cancers. In midday trading on the stock market today, Five Prime lifted nearly 1%, near 27.20.